Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

XOMA: Could their shares ever reach $472.50 again?

|Includes: XOMA Corporation (XOMA)
After an interesting day for XOMA, shares closed at $5.10 (+7.37%).  Investors are probably wondering what will happen next?

If good results come out for the next phase of testing, it's going to be a great beginning for 2011 XOMA investors.  Who knows, could it reach $10? $50? $100?  Is there any chance of it ever making it back up to its all time high of $472.50?  Let's entertain that idea for a moment shall we?  If you had 20 shares at the current $5.10, it would be worth about $102 without the cost of commission.  Goes up to $10 a share, you just doubled your investment.  Goes up to $100 a share, you are now worth $2000.  Let's not stop there; if it ever had the chance to go back up to $472.50 a share, that would be $9450.  All you invested was a $102.  Are you willing to take that risk if there is even a minute chance of the shares going up that high?

Currently, over 23.6 million people in the United States (7.8% of the population) have diabetes.  XOMA 052 could help the lives of all these people. Providing once per month doses.  Only good news is expected from XOMA 052’s clinical trials.  XOMA 052 is also in trials for Rheumatoid Arthritis, Cardiovascular Disease, Behcet’s Uveitis, and Systemic Juvenile Idiopathic Arthritis.

This is the moment we have been waiting for.  Do you want to look back and know that you could of been a part of it, but wasn't?  XOMA 052 is a drug that will help the lives of millions.  This is history in the making.

If you haven't had the chance to check out the results for XOMA 052, here's a link.


Disclosure: I am long XOMA.